ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Cosmo Pharmaceuticals Nv

Cosmo Pharmaceuticals Nv (0RGI)

126,90
0,00
(0,00%)
Fermé 21 Janvier 5:30PM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
126,90
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
1
0,00 Fourchette du Jour 0,00
126,90 Plage de 52 semaines 126,90
Cap du marché
Clôture Veille
126,90
Ouverture
-
Dernière Transaction
1
@
64.8
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
449
Actions en circulation
17 543 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-451,44
Bénéfice par action (BPA)
-0,28
Chiffre d'affairess
94,23M
Bénéfice net
-4,93M

À propos de Cosmo Pharmaceuticals Nv

Secteur
Pharmaceutical Preparations
Industrie
Medicinal Chems,botanicl Pds
Siège social
Dublin, Irl
Fondé
1997
Cosmo Pharmaceuticals Nv est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0RGI. Le dernier cours de clôture d'Cosmo Pharmaceuticals Nv était de CHF126,90. Au cours de la dernière année, les actions de Cosmo Pharmaceuticals Nv ont été négociées dans une fourchette de prix de CHF 126,90 à CHF 126,90.

Cosmo Pharmaceuticals Nv compte actuellement 17 543 000 actions en circulation. La capitalisation boursière d'Cosmo Pharmaceuticals Nv est de CHF2,23 milliard. Cosmo Pharmaceuticals Nv a un ratio cours/bénéfice (ratio PE) de -451.44.

0RGI Dernières nouvelles

Invitation to Cosmo's GI Genius™ Q&A session for investors, analysts and journalist

Invitation to Cosmo's GI Genius™ Q&A session for investors, analysts and journalist PR Newswire DUBLIN, April 28, 2021 DUBLIN, April 28, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX:...

Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device f...

Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy PR Newswire DUBLIN, April 12...

Cosmo Full-Year Report 2020: Cosmo returns to operating profit

Cosmo Full-Year Report 2020: Cosmo returns to operating profit PR Newswire DUBLIN, March 26, 2021 DUBLIN, March 26, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) reports Full-Year...

Invitation to Cosmo's 2020 results / 2021 outlook presentation conference call on 26 March 2021

Invitation to Cosmo's 2020 results / 2021 outlook presentation conference call on 26 March 2021 PR Newswire DUBLIN, March 19, 2021 DUBLIN, March 19, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals NV...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
100126.9126.9126.9179126.9DE
400126.9126.9126.9334126.9DE
1200126.9126.9126.9449126.9DE
2600126.9126.9126.9541126.9DE
5200126.9126.9126.9819126.9DE
15600126.9126.9126.91114126.9DE
26000126.9126.9126.9921126.9DE

0RGI - Frequently Asked Questions (FAQ)

What is the current Cosmo Pharmaceuticals Nv share price?
The current share price of Cosmo Pharmaceuticals Nv is CHF 126,90
How many Cosmo Pharmaceuticals Nv shares are in issue?
Cosmo Pharmaceuticals Nv has 17 543 000 shares in issue
What is the market cap of Cosmo Pharmaceuticals Nv?
The market capitalisation of Cosmo Pharmaceuticals Nv is CHF 2,23B
What is the 1 year trading range for Cosmo Pharmaceuticals Nv share price?
Cosmo Pharmaceuticals Nv has traded in the range of CHF 126,90 to CHF 126,90 during the past year
What is the PE ratio of Cosmo Pharmaceuticals Nv?
The price to earnings ratio of Cosmo Pharmaceuticals Nv is -451,44
What is the cash to sales ratio of Cosmo Pharmaceuticals Nv?
The cash to sales ratio of Cosmo Pharmaceuticals Nv is 23,62
What is the reporting currency for Cosmo Pharmaceuticals Nv?
Cosmo Pharmaceuticals Nv reports financial results in EUR
What is the latest annual turnover for Cosmo Pharmaceuticals Nv?
The latest annual turnover of Cosmo Pharmaceuticals Nv is EUR 94,23M
What is the latest annual profit for Cosmo Pharmaceuticals Nv?
The latest annual profit of Cosmo Pharmaceuticals Nv is EUR -4,93M
What is the registered address of Cosmo Pharmaceuticals Nv?
The registered address for Cosmo Pharmaceuticals Nv is RIVERSIDE II, SIR JOHN ROGERSON’S QUAY, DUBLIN, 20020
What is the Cosmo Pharmaceuticals Nv website address?
The website address for Cosmo Pharmaceuticals Nv is www.cosmopharmaceuticals.com
Which industry sector does Cosmo Pharmaceuticals Nv operate in?
Cosmo Pharmaceuticals Nv operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NTOGNostra Terra Oil And Gas Company Plc
0,043p
(36,51%)
524,2M
BSFABsf Enterprise Plc
3,375p
(35,00%)
13,75M
STBSecure Trust Bank Plc
465,00p
(33,62%)
929,66k
TIATialis Essential It Plc
26,50p
(23,26%)
105,62k
CBGClose Brothers Group Plc
298,40p
(21,90%)
4,6M
NTQEnteq Technologies Plc
1,25p
(-23,31%)
3,22M
BANKFiinu Plc
8,625p
(-15,85%)
21,19M
TIRTiger Royalties And Investments Plc
0,135p
(-15,63%)
75,44M
RCGHRc365 Holding Plc
1,80p
(-14,29%)
1,7M
INDIIndus Gas Limited
7,80p
(-13,33%)
214,66k
NTVONativo Resources Plc
0,0021p
(0,00%)
2,71B
PREMPremier African Minerals Limited
0,026p
(-3,70%)
623,1M
NTOGNostra Terra Oil And Gas Company Plc
0,043p
(36,51%)
524,2M
TRPTower Resources Plc
0,0305p
(0,00%)
504,66M
SYMESupply@me Capital Plc
0,003p
(-3,23%)
469,16M
Aucune Discussion Trouvée
Ajouter une Discussion